Literature DB >> 23021131

Human papillomavirus: what every provider should know.

Britt K Erickson1, Ronald D Alvarez, Warner K Huh.   

Abstract

Persistence of human papillomavirus (HPV) infection is necessary for the development of cervical cancer. Additionally, infection with HPV is implicated in the majority of cases of other genital tract malignancies including vulvar, penile, and vaginal cancer. HPV testing and vaccination are a routine part of obstetrical/gynecological clinical practice. With an enhanced public awareness of HPV infections, many patients turn to their obstetricians/gynecologists with questions about transmission, testing, and prevention. In this review, we will discuss the biology of HPV, epidemiology of disease, methods and indications for testing, and vaccination strategies.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23021131      PMCID： PMC3549042          DOI： 10.1016/j.ajog.2012.09.007

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


  71 in total

1.  Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females.

Authors:  A B Moscicki; N Hills; S Shiboski; K Powell; N Jay; E Hanson; S Miller; L Clayton; S Farhat; J Broering; T Darragh; J Palefsky
Journal:  JAMA       Date:  2001-06-20       Impact factor: 56.272

2.  Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006.

Authors:  Susan Hariri; Elizabeth R Unger; Maya Sternberg; Eileen F Dunne; David Swan; Sonya Patel; Lauri E Markowitz
Journal:  J Infect Dis       Date:  2011-08-15       Impact factor: 5.226

3.  The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States.

Authors:  Anna R Giuliano; Eduardo Lazcano-Ponce; Luisa L Villa; Roberto Flores; Jorge Salmeron; Ji-Hyun Lee; Mary R Papenfuss; Martha Abrahamsen; Emily Jolles; Carrie M Nielson; Maria Luisa Baggio; Roberto Silva; Manuel Quiterio
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

4.  A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection.

Authors:  L A Koutsky; K K Holmes; C W Critchlow; C E Stevens; J Paavonen; A M Beckmann; T A DeRouen; D A Galloway; D Vernon; N B Kiviat
Journal:  N Engl J Med       Date:  1992-10-29       Impact factor: 91.245

5.  2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ.

Authors:  Thomas C Wright; L Stewart Massad; Charles J Dunton; Mark Spitzer; Edward J Wilkinson; Diane Solomon
Journal:  J Low Genit Tract Dis       Date:  2007-10       Impact factor: 1.925

6.  The natural history of type-specific human papillomavirus infections in female university students.

Authors:  Harriet Richardson; Gail Kelsall; Pierre Tellier; Hélène Voyer; Michal Abrahamowicz; Alex Ferenczy; François Coutlée; Eduardo L Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-06       Impact factor: 4.254

7.  HPV prevalence among healthy Italian male sexual partners of women with cervical HPV infection.

Authors:  Maria Benevolo; Marcella Mottolese; Ferdinando Marandino; Mariantonia Carosi; Maria Grazia Diodoro; Steno Sentinelli; Paolo Visca; Francesca Rollo; Luciano Mariani; Giuseppe Vocaturo; Roberto Sindico; Irene Terrenato; Raffaele Perrone Donnorso; Amina Vocaturo
Journal:  J Med Virol       Date:  2008-07       Impact factor: 2.327

8.  Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials.

Authors:  Kevin A Ault
Journal:  Lancet       Date:  2007-06-02       Impact factor: 79.321

Review 9.  Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors.

Authors:  Jennifer S Smith; Danielle M Backes; Brooke E Hoots; Robert J Kurman; Jeanne M Pimenta
Journal:  Obstet Gynecol       Date:  2009-04       Impact factor: 7.661

10.  Transmission of human papillomavirus in heterosexual couples.

Authors:  Brenda Y Hernandez; Lynne R Wilkens; Xuemei Zhu; Pamela Thompson; Katharine McDuffie; Yurii B Shvetsov; Lori E Kamemoto; Jeffrey Killeen; Lily Ning; Marc T Goodman
Journal:  Emerg Infect Dis       Date:  2008-06       Impact factor: 6.883
View more
  13 in total

Review 1.  Human papillomavirus and cervical cancer.

Authors:  Kehinde Sharafadeen Okunade
Journal:  J Obstet Gynaecol       Date:  2019-09-10       Impact factor: 1.246

2.  Knowledge and perception of human papilloma virus vaccine among the antenatal women in a Nigerian tertiary hospital.

Authors:  Teddy E Agida; Godwin O Akaba; Aliyu Y Isah; Bissalla Ekele
Journal:  Niger Med J       Date:  2015 Jan-Feb

3.  Estimation of the prevalence and distribution of HPV genotypes and identification of related risk factors among Turkish women.

Authors:  Mehmet Kulhan; Nur G Kulhan; Yasemin Seven; Umit A Nayki; Cenk Nayki; Nahit Ata; Pasa Ulug
Journal:  Contemp Oncol (Pozn)       Date:  2017-09-29

4.  Chlamydia trachomatis and Human Papillomavirus Infection in Women From Southern Hunan Province in China: A Large Observational Study.

Authors:  Hongliang Chen; Lipei Luo; Yating Wen; Bei He; Hua Ling; Jinwei Shui; Ping He; Xiaoli Hou; Shixing Tang; Zhongyu Li
Journal:  Front Microbiol       Date:  2020-05-05       Impact factor: 5.640

5.  HPV genotype distribution among women with normal and abnormal cervical cytology in Turkey.

Authors:  T Muderris; I Afsar; A Yıldız; C Akpınar Varer
Journal:  Rev Esp Quimioter       Date:  2019-10-23       Impact factor: 1.553

Review 6.  The prevalence and risk of human papillomavirus infection in pregnant women.

Authors:  P Liu; L Xu; Y Sun; Z Wang
Journal:  Epidemiol Infect       Date:  2014-03-25       Impact factor: 4.434

Review 7.  HPV infection and vaccination in Systemic Lupus Erythematosus patients: what we really should know.

Authors:  Ingrid Herta Rotstein Grein; Noortje Groot; Marcela Ignacchiti Lacerda; Nico Wulffraat; Gecilmara Pileggi
Journal:  Pediatr Rheumatol Online J       Date:  2016-03-08       Impact factor: 3.054

8.  Knowledge and Acceptability of Human Papillomavirus Vaccination among Women Attending the Gynaecological Outpatient Clinics of a University Teaching Hospital in Lagos, Nigeria.

Authors:  Kehinde S Okunade; Oyebola Sunmonu; Gbemisola E Osanyin; Ayodeji A Oluwole
Journal:  J Trop Med       Date:  2017-12-19

9.  Reducing incidence of cervical cancer: knowledge and attitudes of caregivers in Nigerian city to human papilloma virus vaccination.

Authors:  Adaobi I Bisi-Onyemaechi; Ugo N Chikani; Obinna Nduagubam
Journal:  Infect Agent Cancer       Date:  2018-08-17       Impact factor: 2.965

10.  Parents willingness to vaccinate their daughter against human papilloma virus and its associated factors in Bench-Sheko zone, southwest Ethiopia.

Authors:  Alemnew Destaw; Tewodros Yosef; Biruk Bogale
Journal:  Heliyon       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.